BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹75 Cr | ₹71 Cr | ₹15 Cr | ₹68 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of BLISS GVS PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹75 Cr |
| Mar2024 | ₹71 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹68 Cr |
| Mar2021 | ₹97 Cr |
How is Consolidated Net Profit of BLISS GVS PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹75 Cr | 6.48 | |
| Mar2024 | ₹71 Cr | 371.14 | |
| Mar2023 | ₹15 Cr | -78.04 | |
| Mar2022 | ₹68 Cr | -29.58 | |
| Mar2021 | ₹97 Cr | - | |
Compare Consolidated Net Profit of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,253.2 Cr | 26.6% | 50.1% | 237.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.5% | 1% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.1% | 0.3% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -4.9% | 2.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹112,353.0 Cr | -1.6% | 5.6% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -3.2% | -3.1% | 4.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 26.6% |
50.1% |
237.7% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses